September 29, 2025

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 26.82% Potential Upside in Medical Devices

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, stands out as a formidable force within the medical devices industry. With a staggering market capitalization of $145.48..

Gold’s fresh peak suggests a turning point

Gold’s move above $3800 an ounce reflects a structural shift in currency dynamics and investor strategy...

ResMed Inc. (RMD) Stock Analysis: Exploring a 8.52% Upside Amid Strong Revenue Growth

ResMed Inc. (NYSE: RMD) stands out as a formidable player in the healthcare sector, particularly within the medical instruments and supplies industry. As a leading developer and distributor of medical..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Play with 18.64% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector with its focus on rare neuroendocrine diseases. This Boston-based company is gaining traction among investors, particularly due to its..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating Growth with a 7.97% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) has emerged as a noteworthy player in the healthcare sector, particularly within the medical devices industry. Based in the United States, the company specializes in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: A Potent 58.58% Upside in Biotech

Avidity Biosciences, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. As a company at the forefront of antibody oligonucleotide conjugates (AOCs),..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 24% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to capture the attention of investors with its robust standing in the biotechnology sector. With a market capitalization of nearly $99 billion, Vertex is..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Riding on a 92.10% Revenue Growth Wave

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is capturing investor attention with its impressive revenue growth of 92.10%. With a market capitalization of $5.63 billion,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Potential 22% Upside with Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, has been making waves with its pioneering genetic medicine solutions targeting high unmet medical needs. Headquartered in Pittsburgh,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring A 29% Upside Potential for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in South Jordan, Utah, this company has been..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 28% Upside with Strong Analyst Confidence

Royalty Pharma plc (NASDAQ: RPRX), a unique player in the healthcare sector, presents a compelling investment opportunity with a potential upside of 28.42% based on current analyst ratings. The company,..

CVS Health Corporation (CVS): Investor Outlook on a Healthcare Powerhouse with a Promising 8.88% Upside

CVS Health Corporation (NYSE: CVS) stands as a stalwart in the healthcare sector, particularly in the expansive domain of healthcare plans. With its roots firmly planted in the United States..

Integer Holdings Corporation (ITGR) Stock Analysis: A 38.79% Upside Potential in the Healthcare Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical devices industry, presents an intriguing investment opportunity with a notable upside potential. With a market cap of $3.56 billion,..

Nuvalent, Inc. (NUVL) Stock Analysis: Unlocking a 43% Potential Upside with Promising Cancer Therapies

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is making waves in the healthcare sector with its innovative approach to cancer treatment. Specializing in the development..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with a 32.50% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector, capturing investor attention with its remarkable revenue growth and significant potential upside. With a market capitalization of $9.57..

DexCom, Inc. (DXCM) Investor Outlook: Analyzing the 50.77% Potential Upside in the Continuous Glucose Monitoring Market

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector, particularly within the medical devices industry, has captured the attention of investors with its promising growth trajectory in the continuous..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unpacking a 23.53% Potential Upside in the Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneering company in the medical devices industry, has captured investor attention with its innovative solutions for organ transplant therapy. With a market capitalization of..

Vaxcyte, Inc. (PCVX) Stock Report: Exploring a Potential 212.93% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company, is making significant waves in the healthcare sector with its innovative approach to vaccine development. Specializing in conjugate and novel protein vaccines..

Waystar Holding Corp. (WAY) Stock Analysis: A 32.59% Potential Upside Beckons Investors

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, is currently attracting significant attention from investors due to its promising growth potential and robust market positioning...

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 28% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a stalwart in the biotechnology sector, has been making waves in the healthcare industry with its innovative therapies. With a market cap of $59.77 billion,..

Search

Funds

September 29, 2025

Gold’s fresh peak suggests a turning point

Gold’s move above $3800 an ounce reflects a structural shift in currency dynamics and investor strategy...
Search

Funds

September 29, 2025

FTSE 100

Funds